Stay updated on Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of March 4, 2025.
    Difference
    0.1%
    Check dated 2025-03-27T14:46:47.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has updated its date references, removing older dates and adding new ones for March 2025.
    Difference
    0.2%
    Check dated 2025-03-06T01:09:13.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.7%
    Check dated 2025-02-26T19:59:34.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing older dates and adding new ones for February 2025.
    Difference
    0.2%
    Check dated 2025-02-18T13:52:27.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting NLM-NCBI services and updates the dates for upcoming events, removing two previous dates.
    Difference
    0.9%
    Check dated 2025-02-11T10:09:30.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.0%
    Check dated 2025-02-04T06:38:27.000Z thumbnail image

Stay in the know with updates to Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.